5247 related articles for article (PubMed ID: 22977525)
1. Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44.
Funato K; Yamazumi Y; Oda T; Akiyama T
Exp Ther Med; 2011 May; 2(3):457-463. PubMed ID: 22977525
[TBL] [Abstract][Full Text] [Related]
2. Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.
Walia V; Prickett TD; Kim JS; Gartner JJ; Lin JC; Zhou M; Rosenberg SA; Elble RC; Solomon DA; Waldman T; Samuels Y
Hum Mutat; 2014 Nov; 35(11):1301-10. PubMed ID: 25113440
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.
Yu X; Zhang F; Mao J; Lu Y; Li J; Ma W; Fan S; Zhang C; Li Q; Wang B; Song B; Li L
Oncotarget; 2017 Nov; 8(58):98798-98811. PubMed ID: 29228728
[TBL] [Abstract][Full Text] [Related]
4. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase receptor type D (PTPRD)-mediated signaling pathways for the potential treatment of hepatocellular carcinoma: a narrative review.
Huang X; Qin F; Meng Q; Dong M
Ann Transl Med; 2020 Sep; 8(18):1192. PubMed ID: 33241041
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
[TBL] [Abstract][Full Text] [Related]
7. Loss of Tyrosine Phosphatase Delta Promotes Gastric Cancer Progression via Signal Transducer and Activator of Transcription 3 Pathways.
Wu L; Gao L; Kong D; Xue H
Dig Dis Sci; 2019 Nov; 64(11):3164-3172. PubMed ID: 31041642
[TBL] [Abstract][Full Text] [Related]
8. miR-516a-3p promotes proliferation, migration, and invasion and inhibits apoptosis in lung adenocarcinoma by targeting PTPRD.
Wu A; Yang X; Zhang B; Wang S; Li G
Int J Clin Exp Pathol; 2019; 12(11):4222-4231. PubMed ID: 31933822
[No Abstract] [Full Text] [Related]
9. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
Acun T; Demir K; Oztas E; Arango D; Yakicier MC
OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062
[TBL] [Abstract][Full Text] [Related]
10. Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.
Solomon DA; Kim JS; Cronin JC; Sibenaller Z; Ryken T; Rosenberg SA; Ressom H; Jean W; Bigner D; Yan H; Samuels Y; Waldman T
Cancer Res; 2008 Dec; 68(24):10300-6. PubMed ID: 19074898
[TBL] [Abstract][Full Text] [Related]
11. Manipulating PTPRD function with ectodomain antibodies.
Qian Z; Song D; Ipsaro JJ; Bautista C; Joshua-Tor L; Yeh JT; Tonks NK
Genes Dev; 2023 Aug; 37(15-16):743-759. PubMed ID: 37669874
[TBL] [Abstract][Full Text] [Related]
12. In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.
Orton S; Karkia R; Mustafov D; Gharanei S; Braoudaki M; Filipe A; Panfilov S; Saravi S; Khan N; Kyrou I; Karteris E; Chatterjee J; Randeva HS
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339334
[TBL] [Abstract][Full Text] [Related]
13. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.
Kohno T; Otsuka A; Girard L; Sato M; Iwakawa R; Ogiwara H; Sanchez-Cespedes M; Minna JD; Yokota J
Genes Chromosomes Cancer; 2010 Apr; 49(4):342-52. PubMed ID: 20073072
[TBL] [Abstract][Full Text] [Related]
14. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin.
Bae WJ; Ahn JM; Byeon HE; Kim S; Lee D
J Exp Clin Cancer Res; 2019 Dec; 38(1):484. PubMed ID: 31805999
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Peyser ND; Du Y; Li H; Lui V; Xiao X; Chan TA; Grandis JR
PLoS One; 2015; 10(8):e0135750. PubMed ID: 26267899
[TBL] [Abstract][Full Text] [Related]
16. The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis.
Tomita H; Cornejo F; Aranda-Pino B; Woodard CL; Rioseco CC; Neel BG; Alvarez AR; Kaplan DR; Miller FD; Cancino GI
Cell Rep; 2020 Jan; 30(1):215-228.e5. PubMed ID: 31914388
[TBL] [Abstract][Full Text] [Related]
17.
Hsu HC; Lapke N; Chen SJ; Lu YJ; Jhou RS; Yeh CY; Tsai WS; Hung HY; Hsieh JC; Yang TS; Thiam TK; You JF
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30200630
[TBL] [Abstract][Full Text] [Related]
18. High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.
Giefing M; Zemke N; Brauze D; Kostrzewska-Poczekaj M; Luczak M; Szaumkessel M; Pelinska K; Kiwerska K; Tönnies H; Grenman R; Figlerowicz M; Siebert R; Szyfter K; Jarmuz M
Genes Chromosomes Cancer; 2011 Mar; 50(3):154-66. PubMed ID: 21213369
[TBL] [Abstract][Full Text] [Related]
19. PTPRD silencing by DNA hypermethylation decreases insulin receptor signaling and leads to type 2 diabetes.
Chen YT; Lin WD; Liao WL; Lin YJ; Chang JG; Tsai FJ
Oncotarget; 2015 May; 6(15):12997-3005. PubMed ID: 26079428
[TBL] [Abstract][Full Text] [Related]
20. Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Uhl GR; Martinez MJ; Paik P; Sulima A; Bi GH; Iyer MR; Gardner E; Rice KC; Xi ZX
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11597-11602. PubMed ID: 30348770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
